BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14640875)

  • 1. Intestinal metaplasia: evolution after Helicobacter pylori eradication and influence in the success of eradicating therapy.
    Vázquez Romero M; Boixeda de Miquel D; Valer López-Fando MP; Albéniz Arbizu E; González Alonso R; Bermejo San José F
    Rev Esp Enferm Dig; 2003 Nov; 95(11):781-4, 777-80. PubMed ID: 14640875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Helicobacter pylori infection and eradication on proliferative kinetics of the gastric mucosa].
    Unger Z; Prónai L; Szaleczky E; Zágoni T; Molnár B; Tulassay Z
    Orv Hetil; 2000 Dec; 141(50):2695-700. PubMed ID: 11189675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gastric mucosa lesions in gastric ulcer disease. Initial study and 1-year follow-up after Helicobacter pylori eradication].
    Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Martín de Argila C
    Gastroenterol Hepatol; 2000; 23(6):269-74. PubMed ID: 15324621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.
    Zhou L; Sung JJ; Lin S; Jin Z; Ding S; Huang X; Xia Z; Guo H; Liu J; Chao W
    Chin Med J (Engl); 2003 Jan; 116(1):11-4. PubMed ID: 12667379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori eradication and antral intestinal metaplasia--two years follow-up study.
    Ciok J; Dzieniszewski J; Lucer C
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():115-22. PubMed ID: 9440062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori eradication treatment modulates epithelial cell proliferation and tissue content of hepatocyte growth factor in the gastric mucosa.
    Suzuki M; Suzuki H; Masaoka T; Tanaka S; Suzuki K; Ishii H
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():158-64. PubMed ID: 15298622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.
    Arkkila PE; Seppälä K; Färkkilä MA; Veijola L; Sipponen P
    Scand J Gastroenterol; 2006 Jul; 41(7):782-90. PubMed ID: 16785190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of eradication treatment on histological changes of the gastric mucosa in patients with non-ulcer dyspesia and Helicobacter pylori infection. Randomized prospective study].
    Kyzeková J
    Vnitr Lek; 1999 Feb; 45(2):90-6. PubMed ID: 15641227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell kinetic balance in gastric mucosa with intestinal metaplasia after Helicobacter pylori eradication: 2-year follow-up study.
    Wambura C; Aoyama N; Shirasaka D; Kuroda K; Watanabe Y; Miki I; Tamura T; Kasuga M
    Dig Liver Dis; 2004 Mar; 36(3):178-86. PubMed ID: 15046186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Helicobacter pylori eradication on extent of duodenal gastric metaplasia and grade of gastritis.
    Bago J; Strinić D; Halle ZB; Jandrić D; Tomić M; Bilić A; Bago P
    Coll Antropol; 2002 Dec; 26(2):557-63. PubMed ID: 12528281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.
    Watari J; Das KK; Amenta PS; Tanabe H; Tanaka A; Geng X; Lin JJ; Kohgo Y; Das KM
    Clin Gastroenterol Hepatol; 2008 Apr; 6(4):409-17. PubMed ID: 18321787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the gastric mucosa following eradication of Helicobacter pylori.
    Genta RM; Lew GM; Graham DY
    Mod Pathol; 1993 May; 6(3):281-9. PubMed ID: 8346176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New ultrashort scheme for helicobacter pylori infection eradication using tetracyline, furazolidone and colloidal bismuth subcitrate in dyspeptic patients with or without peptic ulceration in the National Hospital Cayetano Heredia].
    Araujo Castillo R; Pinto Valdivia JL; Ramírez D; Cok García J; Bussalleu Rivera A
    Rev Gastroenterol Peru; 2005; 25(1):23-41. PubMed ID: 15818420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Helicobacter pylori Infection on gastric mucin expression.
    Kang HM; Kim N; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Lee HS; Jung HC; Song IS
    J Clin Gastroenterol; 2008 Jan; 42(1):29-35. PubMed ID: 18097286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis.
    Wang J; Xu L; Shi R; Huang X; Li SW; Huang Z; Zhang G
    Digestion; 2011; 83(4):253-60. PubMed ID: 21282951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term celecoxib to regress long-term persistent gastric intestinal metaplasia after Helicobacter pylori eradication.
    Hung KH; Yang HB; Cheng HC; Wu JJ; Sheu BS
    J Gastroenterol Hepatol; 2010 Jan; 25(1):48-53. PubMed ID: 19793174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication.
    Yang HB; Cheng HC; Sheu BS; Hung KH; Liou MF; Wu JJ
    Aliment Pharmacol Ther; 2007 Feb; 25(4):455-61. PubMed ID: 17270001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Helicobacter pylori eradication on bulbitis and duodenal gastric metaplasia.
    Suriani R; Venturini I; Actis GC; Rocca G; Rizzetto M; Cerutti E; Mazzucco D; Cardesi E; Zeneroli ML
    Hepatogastroenterology; 2004; 51(55):176-80. PubMed ID: 15011858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type III intestinal metaplasia, Helicobacter pylori infection and gastric carcinoma risk index in an Italian series of 1750 patients.
    Suriani R; Venturini I; Taraglio S; Mazzucco D; Grosso S; Predebon S; Mamo C; Tremosini S; Ballesini P; Borghi A; Zeneroli ML
    Hepatogastroenterology; 2005; 52(61):285-8. PubMed ID: 15783051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.